Spontaneous Remission and Concomitant Progression in a Patient with DLBCL.
Eun Ji HanJihyun KimSuk Young ParkJoo Hyun OPublished in: Diagnostics (Basel, Switzerland) (2020)
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma. Although DLBCL can be cured in more than half of all patients, up to 50% of patients become refractory to initial treatment or relapse after complete remission. We present a case of complete spontaneous remission of some tumors and concomitant newly developed tumors observed in a patient with relapsed DLBCL. Spontaneous remission of lymphoma without treatment is a rare phenomenon and can occur at baseline as well as in relapsed DLBCL. However, most patients who initially experience spontaneous remission later develop relapse. Thus, careful follow-up is required, and fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) allows monitoring of multiple lesions.
Keyphrases
- diffuse large b cell lymphoma
- positron emission tomography
- computed tomography
- epstein barr virus
- end stage renal disease
- pet ct
- pet imaging
- chronic kidney disease
- disease activity
- ejection fraction
- newly diagnosed
- ulcerative colitis
- peritoneal dialysis
- dual energy
- contrast enhanced
- rheumatoid arthritis
- case report
- prognostic factors
- systemic lupus erythematosus
- replacement therapy